ATE397460T1 - Pharmazeutische zusammensetzung auf der basis von azaliden für lokale anwendung in der ophtalmologie - Google Patents

Pharmazeutische zusammensetzung auf der basis von azaliden für lokale anwendung in der ophtalmologie

Info

Publication number
ATE397460T1
ATE397460T1 AT02732804T AT02732804T ATE397460T1 AT E397460 T1 ATE397460 T1 AT E397460T1 AT 02732804 T AT02732804 T AT 02732804T AT 02732804 T AT02732804 T AT 02732804T AT E397460 T1 ATE397460 T1 AT E397460T1
Authority
AT
Austria
Prior art keywords
ophtalmology
azalides
pharmaceutical composition
composition based
local use
Prior art date
Application number
AT02732804T
Other languages
English (en)
Inventor
Jacques Luyckx
Frederic Pilotaz
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Lab filed Critical Thea Lab
Application granted granted Critical
Publication of ATE397460T1 publication Critical patent/ATE397460T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT02732804T 2001-04-12 2002-04-11 Pharmazeutische zusammensetzung auf der basis von azaliden für lokale anwendung in der ophtalmologie ATE397460T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105114A FR2823441B1 (fr) 2001-04-12 2001-04-12 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation

Publications (1)

Publication Number Publication Date
ATE397460T1 true ATE397460T1 (de) 2008-06-15

Family

ID=8862340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02732804T ATE397460T1 (de) 2001-04-12 2002-04-11 Pharmazeutische zusammensetzung auf der basis von azaliden für lokale anwendung in der ophtalmologie

Country Status (30)

Country Link
US (1) US7064109B2 (de)
EP (1) EP1377316B1 (de)
JP (2) JP4558275B2 (de)
KR (1) KR100835002B1 (de)
CN (1) CN1496270B (de)
AR (1) AR034033A1 (de)
AT (1) ATE397460T1 (de)
BR (1) BRPI0208367B8 (de)
CA (1) CA2443728C (de)
CY (1) CY1108302T1 (de)
CZ (1) CZ300213B6 (de)
DE (1) DE60226962D1 (de)
DK (1) DK1377316T3 (de)
EA (1) EA008088B1 (de)
EG (1) EG23169A (de)
ES (1) ES2307754T3 (de)
FR (1) FR2823441B1 (de)
HR (1) HRP20030907B1 (de)
HU (1) HU230459B1 (de)
MA (1) MA27005A1 (de)
MX (1) MXPA03009349A (de)
OA (1) OA12462A (de)
PA (1) PA8543401A1 (de)
PE (1) PE20021082A1 (de)
PL (1) PL204403B1 (de)
PT (1) PT1377316E (de)
SI (1) SI1377316T1 (de)
TN (1) TNSN03091A1 (de)
WO (1) WO2002083178A1 (de)
ZA (1) ZA200307718B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314354T3 (es) * 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
JPWO2007074904A1 (ja) * 2005-12-28 2009-06-04 わかもと製薬株式会社 水性医薬組成物
BRPI0808410A2 (pt) * 2007-02-28 2015-06-23 Aciex Therapeutics Inc Métodos e composições para normalizar secreções da glândula meibomiana
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
CN101780105B (zh) * 2009-01-20 2011-09-28 沈阳兴齐制药有限公司 小牛血去蛋白提取物的滴眼液
EP2228058A1 (de) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionische Öl-in-Wasser-Emulsion mit Prostaglandinen und Verwendungen dafür
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2394636B1 (de) * 2010-05-28 2014-03-19 Novagali Pharma S.A. Verfahren zur Behandlung von Netzhauterkrankungen mit einer intraokularen Tamponade
EP2389939A1 (de) 2010-05-28 2011-11-30 Novagali Pharma S.A. Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
AU2017290256A1 (en) * 2016-06-29 2019-01-17 Otonomy, Inc. Triglyceride otic formulations and uses thereof
PT3266446T (pt) * 2016-07-07 2019-01-30 Salvat Lab Sa Composição oftálmica compreendendo óleo de rícino e triglicérido de cadeia média
CN115475248A (zh) * 2021-06-16 2022-12-16 云南拜奥泰克生物技术有限责任公司 一种新型药用甘油三酯溶剂及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
JPS6468328A (en) * 1987-09-09 1989-03-14 Suntory Ltd Anticorneoulcerative
JP2563336B2 (ja) * 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
EP0925789B2 (de) * 1997-12-02 2009-06-17 Pfizer Products Inc. Verwendung von azithromycin zur topischen behandlung von augeninfektionen
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections

Also Published As

Publication number Publication date
CZ300213B6 (cs) 2009-03-18
BRPI0208367B8 (pt) 2021-05-25
CY1108302T1 (el) 2014-02-12
EG23169A (en) 2004-06-30
JP5170780B2 (ja) 2013-03-27
CN1496270A (zh) 2004-05-12
CA2443728C (fr) 2011-01-04
JP2010043109A (ja) 2010-02-25
ZA200307718B (en) 2004-09-02
AR034033A1 (es) 2004-01-21
HUP0303864A3 (en) 2012-07-30
BR0208367A (pt) 2004-03-09
PL363538A1 (en) 2004-11-29
JP2004526763A (ja) 2004-09-02
EA200301108A1 (ru) 2004-04-29
ES2307754T3 (es) 2008-12-01
KR100835002B1 (ko) 2008-06-09
TNSN03091A1 (fr) 2005-12-23
CN1496270B (zh) 2010-05-26
EA008088B1 (ru) 2007-02-27
JP4558275B2 (ja) 2010-10-06
WO2002083178A1 (fr) 2002-10-24
FR2823441A1 (fr) 2002-10-18
HRP20030907B1 (hr) 2010-04-30
KR20030088466A (ko) 2003-11-19
HRP20030907A2 (en) 2004-02-29
SI1377316T1 (sl) 2008-10-31
DE60226962D1 (de) 2008-07-17
HUP0303864A2 (hu) 2004-03-01
US20040197340A1 (en) 2004-10-07
US7064109B2 (en) 2006-06-20
CZ20032771A3 (cs) 2004-01-14
EP1377316B1 (de) 2008-06-04
MXPA03009349A (es) 2004-11-12
PE20021082A1 (es) 2002-12-18
BR0208367B1 (pt) 2013-11-12
DK1377316T3 (da) 2008-09-22
MA27005A1 (fr) 2004-12-20
PT1377316E (pt) 2008-09-15
PL204403B1 (pl) 2010-01-29
EP1377316A1 (de) 2004-01-07
FR2823441B1 (fr) 2004-09-10
HU230459B1 (hu) 2016-07-28
HK1065708A1 (zh) 2005-03-04
PA8543401A1 (es) 2003-01-24
OA12462A (fr) 2006-06-24
CA2443728A1 (fr) 2002-10-24

Similar Documents

Publication Publication Date Title
ATE279961T1 (de) Neue pharmazeutische zusammensetzung
ATE397460T1 (de) Pharmazeutische zusammensetzung auf der basis von azaliden für lokale anwendung in der ophtalmologie
IS2986B (is) Nýr tilbúinn fjölræsivaki til að nota við meðferð á manneskjum
EE200100391A (et) Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon
DE60213592D1 (de) Flüssige pharmazeutische zusammensetzung
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
ATE355271T1 (de) Pharmazeutische zusammensetzung
NO20025450L (no) Ny farmasöytisk sammensetning
DE60106275T8 (de) Dermatologische zusammensetzung
EE9700363A (et) Uus anesteseeriva toimega farmatseutiline segu
DE50002860D1 (de) Spreizbares medizinisches instrument, insbesondere laryngoskop
DE69932510D1 (de) Vaskularisierungsinhibitoren
DE60336306D1 (de) Photoinitiator, neue verbindung und photohärtbare zusammensetzung
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
EP1512405A4 (de) Zusammensetzung zur linderung von chloasma und zusammensetzung zur linderung von stumpfem aussehen
EE200300355A (et) Neublastiini polümeerkonjugaadid ja meetodid nende kasutamiseks
DE60129238D1 (de) Pharmazeutische zusammensetzung
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DE50311346D1 (de) Formulierung für den einsatz in der chromfrei- oder chromgerbung
DE50311496D1 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und egfr-kinase-hemmern
NO20012030L (no) Kryptografisk signering i små enheter
ITRM20020119A1 (it) Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
ITMI20000279V0 (it) Guanto per uso cosmetico
DE10107261B4 (de) Pharmazeutische Zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1377316

Country of ref document: EP